Creative Medical Technology Holdings Inc. (CELZ) - Operating Margin

Creative Medical Technology - graphic logo of issuer CELZ

Creative Medical Technology is developing the AmnioStem platform, introducing innovations in regenerative therapy. An assessment of operating profitability demonstrates profit dynamics, where -256435.00 becomes the new value for this metric. A narrow business profile creates a dependency on future patents. Meanwhile, regulatory uncertainty and clinical trial costs create significant barriers to the company's potential growth.

CELZ - Creative Medical Technology Holdings Inc. Operating Profit Rate over the range 07/04/2022 - 11/19/2026

Metric breakdowns and analytics for Creative Medical Technology Holdings, Inc. (CELZ)

Finished products of Creative Medical Technology Holdings

Efficient air delivery of cellular materials minimizes logistics costs for Creative Medical Technology (CELZ), directly impacting the operating profit margin before interest and taxes. This ratio reflects the share of core business profit in revenue before financial expenses, allowing investors to assess real capital management efficiency and the company's operational resilience by analyzing the trends on this chart.